PsygaBio is a drug discovery company focused on developing groundbreaking therapeutics derived from natural compounds. Founded by world-renowned cannabis and mushrooms researcher and pioneer Prof. Dedi Meiri from the Technion – Israel Institute of Technology and backed by robust scientific capabilities.
Psyga Bio using Cannasoul’s proprietary analytical platform, data-driven approach, unique knowhow and clinical trial framework supports active compound identification and development, from mushrooms cultivation and extraction through clinical approved formulations.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 5 Tarshish St., North Industrial Park,ceasarea,3079822,israel
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- HQ
- North Industrial Park, Ceasarea
Psygabio Questions
Psygabio's website is https://cannasoul.co.il/psyga-bio/
Psygabio's LinkedIn profile is https://il.linkedin.com/company/psygabio
Psygabio has
6 employees.
View email and phone details for 6
employees at Psygabio.
Psygabio's industry is
Research Services
Psygabio's top competitors are
Memed,
Msics Pharma,
Myplant Bio Ltd,
Psyrx Ltd,
Evogene,
Agrematch,
Proleafera,
Minovia Therapeutics,
Reagenics,
Cannasoul Group.
Psygabio's categories are Research Services
Psygabio's founding year is 2021
